ZUELLIG PHARMA INVESTS IN HEALTH BENEFIT CONSULTANTS

Press Releases » อังคาร 9 พฤษภาคม 2560 14:46 น.

           Zuellig Pharma, the region's leading healthcare services provider, has today announced it has invested in Health Benefit Consultants Company (HBC) through its Malaysian subsidiary – MiCare Sdn Bhd.
          HBC is a leading third party administrator in Thailand providing medical claims administration and related consulting and advisory services to corporates and insurance companies. It was established in 1993 and serves the needs of 17 Thai and three foreign companies.
          Zuellig Pharma Vice President Integrated Solutions Moses Hee said this partnership will focus on growing HBC in Thailand and expanding the services and health benefits it offers to Thai people.
          "We want to work closely with HBC to grow its existing business and help it better serve the needs of local Thai people, companies and insurers. The business is currently responsible for managing the health insurance of 2.5 million Thai people and we believe that there is a lot of potential for growth."
          HBC Managing Director Permsak Natenuj said the partnership will allow HBC to leverage Zuellig Pharma's regional networks and MiCare's technology and expertise.
          "Zuellig Pharma's strong regional networks and focus on developing innovative new solutions will help us to expand HBC's business and the services that we offer. This partnership will enable the development of technology and solutions that will deliver greater health benefits to the Thai people that we support."
          Zuellig Pharma's subsidiary, MiCare, is the leading partner for Payors in Malaysia, offering health and wellness as well as third party administration services to corporates and insurance companies. Zuellig Pharma will leverage MiCare's technology and expertise to bring new services to Thailand, in partnership with HBC.
          "MiCare offers corporates and insurance companies a range of services to improve the health of the people that they insure. This is not only good for the individual, it helps to reduce corporate healthcare and insurance costs," said Mr Hee.
          The solutions being piloted in Malaysia include mobile applications and health and wellness programmes.
          "These programmes are delivering strong results. A recent pilot that we ran with a local Malaysian corporate reduced the number of preventable new cases of chronic disease among its employees by 20% and improved the health of more than 45% of the people that took part.
          "This resulted in a 14% reduction in the company's absentee rate and a 15% reduction in its employee medical expenses. We look forward to introducing similar programmes to the Thai market through our partnership with HBC," said Mr Hee.

ZUELLIG PHARMA INVESTS IN HEALTH BENEFIT CONSULTANTS

Zuellig Pharma Launches "Reduce Size, Reduce Disease" Campaign in Thailand This campaign aims to raise awareness of obesity as a disease and promote healthier lifestyles nationwide

Zuellig Pharma, a leading integrated healthcare solutions company in Asia, has launched the "Reduce Size, Reduce Disease" campaign to raise awareness about obesity, a major public health concern in Thailand affecting up to 48% of the total population?. The Ministry of Public Health classifies obesity as a non-communicable disease (NCD), recognizing the condition as a risk factor for chronic health issues such as type 2 diabetes, high blood pressure, and high cholesterol. Ms. Sunaiyanaa

16 มิถุนายน 2568 14:16 น.

ZUELLIG PHARMA INVESTS IN HEALTH BENEFIT CONSULTANTS

ข่าวZuellig Pharma+o:healวันนี้

Zuellig Pharma Launches "Reduce Size, Reduce Disease" Campaign in Thailand This campaign aims to raise awareness of obesity as a disease and promote healthier lifestyles nationwide